Skip to content
Menu

Labcorp Holdings Inc. LH

Full chart Compare
Set alert

Price alert · LH

All alert types
364.86 USD -3.30 (-0.90%)

As ofNov 18, 2026, 9:41 AM EST

363.00 Day range 366.65
250.39 52-week range 372.46
YTD
+45.43%
1 year
+40.43%
Market cap
29.58B
Revenue (ttm)
14.59B
Profit margin
6.88%
EPS (ttm)
12.20
Shares out
81.20M
P/E ratio
29.86
Forward P/E
18.78
Dividend
2.88 (0.77%)
Ex-dividend date
Nov 24, 2026
YTD return
+45.43%
1-year return
+40.43%
Volume
19.66K
Avg volume
740.18K
Open
365.49
Previous close
368.16
Day's range
363.00 – 366.65
52-week range
250.39 – 372.46
Beta
0.83
Analysts
Buy
Price target
390.06 (+6.9%)
Earnings date
Feb 16, 2027
50-day average
330.55

5D -8.39 (-2.25%)

365370ThuFriMonTueWed364.98

Key statistics

200-day average
292.91
Enterprise value
36.85B
PEG ratio
1.65
Price / sales
2.05
Price / book
3.38
Payout ratio
23.61%
Revenue growth
6.90%
Free cash flow
1.06B
Total cash
261.80M
Total debt
6.85B
Return on equity
11.44%
Short % of float
3.14%

Fundamental scorecard

14 of 25 checks passed on LH’s reported financials

ValueGrowthProfitabilityHealthDividend

14of 25 checks passed

  • Value 1 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health 3 of 5
  • Dividend 4 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
LH Revenue — quarterly 3.81B
LH Net income — quarterly 262.80M
LH EPS — quarterly 3.24

Earnings

LH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 16, 2027Dec 30, 20264.50———
Oct 28, 2026Sep 30, 20264.644.78+0.14+3.02%
Jul 30, 2026Jun 30, 20264.784.99+0.21+4.39%
Apr 30, 2026Mar 31, 20264.114.25+0.14+3.41%
Feb 17, 2026Dec 31, 20253.954.07+0.12+3.04%
Oct 28, 2025Sep 30, 20254.134.18+0.05+1.21%

Upgrades / downgrades

LH analyst upgrades and downgrades
DateFirmActionFromTo
Oct 29, 2026UBSmainBuyBuy
Oct 29, 2026BarclaysmainEqual-WeightEqual-Weight
Oct 29, 2026Truist SecuritiesmainBuyBuy
Oct 29, 2026BairdmainOutperformOutperform
Sep 21, 2026Truist SecuritiesmainBuyBuy
Sep 11, 2026UBSmainBuyBuy

About Labcorp Holdings Inc.

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
labcorp.com

News

Your note

Sign in to keep a note on LH — it syncs with the Stock Master app.

Insider holders

LH insider holders
InsiderRelationLatest transactionDateShares held
ANDERSON KERRII BDirectorSaleAug 16, 20266,851
BERBERIAN LANCE VOfficerStock Award(Grant)Mar 26, 202518,652
CAVENEY BRIAN JOfficerSaleNov 9, 202634,562
EISENBERG GLENN AOfficerStock Award(Grant)Mar 26, 202537,920
KONG GARHENGDirectorConversion of Exercise of derivative securityFeb 10, 202613,739
NEUPERT PETER MDirectorConversion of Exercise of derivative securityFeb 10, 202613,784

Institution ownership

LH institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.05%6,535,5062.41BSep 29, 2026
Vanguard Capital Management LLC6.54%5,309,9301.95BSep 29, 2026
State Street Corporation4.86%3,943,5511.45BSep 29, 2026
Victory Capital Management Inc.4.83%3,918,5781.44BSep 29, 2026
FMR, LLC4.54%3,689,5521.36BSep 29, 2026
Vanguard Portfolio Management LLC4.46%3,618,7701.33BSep 29, 2026

Fund ownership

LH fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.21%2,603,810958.62MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.62%2,124,615782.20MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.19%1,776,838654.16MJun 29, 2026
ALLSPRING FUNDS TRUST-Allspring Special Mid Cap Value Fund1.80%1,462,400538.40MSep 29, 2026
Victory Portfolios-Victory Sycamore Established Value Fund1.78%1,445,000531.99MJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%1,080,629397.84MSep 29, 2026